Loading...
Loading...
Beyond SSRIs. Targeting neuroplasticity—the brain's ability to rewire itself—rather than just modulating neurotransmitter levels.
Traditional psychiatry artificially props up serotonin.
The Peptide Approach targets Neuroplasticity. We don't just want to feel better temporarily; we want to enhance the brain's physical capacity to heal, adapt, and grow new connections.
| Peptide | Primary Action | Best For | Route |
|---|---|---|---|
| Semax | ↑ BDNF, Dopamine | Depression, ADHD | Nasal, SubQ |
| Selank | ↓ Anxiety, ↑ GABA | Anxiety, Stress | Nasal, SubQ |
| Dihexa | ↑↑ Neuroplasticity | Cognitive Decline | Oral, SubQ |
| BPC-157 | ↑ Dopamine Rec. | Anhedonia, Recovery | Oral, SubQ |
| DSIP | ↓ Cortisol, Sleep | Insomnia, Burnout | SubQ |
BDNF is "Miracle-Gro" for the brain. Low BDNF correlates with depression more strongly than low serotonin.
Semax (+500%) • Selank (+300%) • Dihexa (+1000%)